Abstract
Tamoxifen, a selective estrogen receptor modulator, has been used in the treatment of peripheral precoccious puberty. A 5-year and 3-month-old girl, diagnosed with McCune-Albright syndrome, came in with abnormal hair growth approximately 2 months after the initiation of tamoxifen. The pattern of terminal hair on the skin following the administration of the drug and the exclusion of other causes suggested tamoxifen-induced hirsutism.
References
1. Mieszczak J, Eugster EA. Treatment of precocious puberty in McCune-Albright syndrome. Pediatr Endocrinol Rev 2007;4: 419–22.Search in Google Scholar
2. Eugster EA, Rubin SD, Reiter EO, Plourde P, Jou HC, et al. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. J Pediatr 2003;143:60–6.10.1016/S0022-3476(03)00128-8Search in Google Scholar
3. Hohl A, Ronsoni MF, Oliveira M. Hirsutism: diagnosis and treatment. Arq Bras Endocrinol Metab 2014;58:97–107.10.1590/0004-2730000002923Search in Google Scholar PubMed
4. Ferriman DM, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol 1961;21:1440–7.10.1210/jcem-21-11-1440Search in Google Scholar PubMed
5. Al-Niaimi F, Lyon C. Tamoxifen-induced hirsutism. J Drugs Dermatol 2011;10:799–801.Search in Google Scholar
6. Nolvadex Side Effects Center. Review: could tamoxifen citrate cause hrsutism? Feb, 26, 2014 (eHealthMe).Search in Google Scholar
7. Zhou J, Ng S, Famuiya OA, Anderson K, Bondy CA. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. The FASEB J 2000;14:1725–30.10.1096/fj.99-0863comSearch in Google Scholar PubMed
©2015 by De Gruyter
